First Eagle Investment Management LLC acquired a new stake in shares of Progyny, Inc. (NASDAQ:PGNY – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 144,900 shares of the company’s stock, valued at approximately $2,500,000.
Other hedge funds also recently modified their holdings of the company. Leibman Financial Services Inc. boosted its holdings in shares of Progyny by 100.7% during the 4th quarter. Leibman Financial Services Inc. now owns 63,509 shares of the company’s stock valued at $1,096,000 after acquiring an additional 31,872 shares in the last quarter. Fort Washington Investment Advisors Inc. OH boosted its holdings in shares of Progyny by 90.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 1,467,780 shares of the company’s stock valued at $25,319,000 after acquiring an additional 695,740 shares in the last quarter. Aurora Investment Counsel acquired a new stake in shares of Progyny during the 3rd quarter valued at $1,280,000. Clear Harbor Asset Management LLC acquired a new stake in shares of Progyny during the 4th quarter valued at $989,000. Finally, Barclays PLC raised its position in Progyny by 530.4% during the 3rd quarter. Barclays PLC now owns 706,157 shares of the company’s stock worth $11,835,000 after purchasing an additional 594,140 shares during the last quarter. Institutional investors and hedge funds own 94.93% of the company’s stock.
Progyny Trading Up 2.6 %
PGNY stock opened at $20.36 on Friday. The stock has a 50-day moving average price of $21.58 and a 200-day moving average price of $18.64. Progyny, Inc. has a 1-year low of $13.39 and a 1-year high of $38.98. The firm has a market cap of $1.74 billion, a PE ratio of 35.10, a price-to-earnings-growth ratio of 2.39 and a beta of 1.41.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on PGNY
Insider Buying and Selling
In related news, CEO Peter Anevski acquired 209,500 shares of the firm’s stock in a transaction on Monday, December 23rd. The stock was purchased at an average cost of $14.48 per share, with a total value of $3,033,560.00. Following the acquisition, the chief executive officer now owns 441,463 shares of the company’s stock, valued at approximately $6,392,384.24. This trade represents a 90.32 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Chairman David J. Schlanger acquired 150,000 shares of the firm’s stock in a transaction on Thursday, December 26th. The shares were bought at an average cost of $14.68 per share, with a total value of $2,202,000.00. Following the completion of the acquisition, the chairman now directly owns 228,269 shares in the company, valued at approximately $3,350,988.92. This represents a 191.65 % increase in their position. The disclosure for this purchase can be found here. 12.30% of the stock is owned by company insiders.
About Progyny
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Featured Articles
- Five stocks we like better than Progyny
- What Does a Stock Split Mean?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- The 3 Best Fintech Stocks to Buy Now
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How is Compound Interest Calculated?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding PGNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Progyny, Inc. (NASDAQ:PGNY – Free Report).
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.